Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.
Weisser M, Schleuning M, Ledderose G, Rolf B, Schnittger S, Schoch C, Schwerdtfeger R, Kolb HJ. Weisser M, et al. Among authors: schleuning m. Bone Marrow Transplant. 2004 Dec;34(12):1083-8. doi: 10.1038/sj.bmt.1704664. Bone Marrow Transplant. 2004. PMID: 15489879 Clinical Trial.
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.
Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weissinger E, Bunjes D, Harsdorf SV, Scheid C, Holtick U, Greinix H, Keil F, Schneider B, Sandherr M, Bug G, Tischer J, Ledderose G, Hallek M, Hiddemann W, Kolb HJ. Schmid C, et al. Among authors: schleuning m. Blood. 2006 Aug 1;108(3):1092-9. doi: 10.1182/blood-2005-10-4165. Epub 2006 Mar 21. Blood. 2006. PMID: 16551971 Free article. Clinical Trial.
[Allogeneic transplantation in malignant lymphoma].
Stötzer OJ, Schleuning M, Ledderose G, Hiddemann W, Kolb HJ. Stötzer OJ, et al. Among authors: schleuning m. Dtsch Med Wochenschr. 2001 Sep 28;126(39):1062-9. doi: 10.1055/s-2001-17492. Dtsch Med Wochenschr. 2001. PMID: 11602913 German.
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.
Schmid C, Schleuning M, Tischer J, Holler E, Haude KH, Braess J, Haferlach C, Baurmann H, Oruzio D, Hahn J, Spiekermann K, Schlimok G, Schwerdtfeger R, Buechner T, Hiddemann W, Kolb HJ. Schmid C, et al. Among authors: schleuning m. Bone Marrow Transplant. 2012 Jan;47(1):46-53. doi: 10.1038/bmt.2011.15. Epub 2011 Feb 28. Bone Marrow Transplant. 2012. PMID: 21358688 Clinical Trial.
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F).
Holler E, Kolb HJ, Mittermüller J, Kaul M, Ledderose G, Duell T, Seeber B, Schleuning M, Hintermeier-Knabe R, Ertl B, et al. Holler E, et al. Among authors: schleuning m. Blood. 1995 Aug 1;86(3):890-9. Blood. 1995. PMID: 7620183 Free article. Clinical Trial.
128 results